Cite
HARVARD Citation
Yu, L. et al. (2018). Preparation and anti-cancer evaluation of promiximab-MMAE, an anti-CD56 antibody drug conjugate, in small cell lung cancer cell line xenograft models. Journal of drug targeting. pp. 905-912. [Online].